DOUGLASS CHESTER W 4
4 · QUINTILES TRANSNATIONAL CORP · Filed Sep 29, 2003
Insider Transaction Report
Form 4
DOUGLASS CHESTER W
Director
Transactions
- Disposition to Issuer
Common Stock
2003-09-25−285,500→ 0 total - Disposition to Issuer
Common Stock
2003-09-25−117,000→ 0 total(indirect: By Partnership) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−6,000→ 0 totalExercise: $4.32Exp: 2003-12-01→ Common Stock (6,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−5,000→ 0 totalExercise: $33.13Exp: 2006-12-31→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−2,352→ 0 totalExercise: $17.75Exp: 2012-03-31→ Common Stock (2,352 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−4,242→ 0 totalExercise: $38.25Exp: 2007-12-31→ Common Stock (4,242 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−3,001→ 0 totalExercise: $52.13Exp: 2008-12-08→ Common Stock (3,001 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−8,432→ 0 totalExercise: $18.69Exp: 2010-01-01→ Common Stock (8,432 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−12,000→ 0 totalExercise: $13.50Exp: 2010-05-26→ Common Stock (12,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−3,208→ 0 totalExercise: $13.09Exp: 2012-06-15→ Common Stock (3,208 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−3,562→ 0 totalExercise: $12.11Exp: 2012-12-16→ Common Stock (3,562 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−7,926→ 0 totalExercise: $20.94Exp: 2011-01-01→ Common Stock (7,926 underlying) - Disposition to Issuer
Stock Option (right to buy)
2003-09-25−4,467→ 0 totalExercise: $9.76Exp: 2012-09-16→ Common Stock (4,467 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated April 10, 2003, as amended, by and among Quintiles, Pharma Services Holding, Inc. ("Pharma Services") and Pharma Services Acquisition Corp. (the "Merger Agreement") in exchange for (i) 743,437.2436 shares of common stock of Pharma Services, (ii) 3,443.75 shares of preferred stock of Pharma Services and (iii) an aggregate cash payment equal to $2,356,250. The cash payment represents the aggregate total paid to the reporting person for all options with an exercise price less than $14.50 that were not disposed of in exchange for equity securities of Pharma Services. The cash payment for each option was derived by taking the excess, if any, of $14.50 over the per share exercise price of such option and multiplying the result by the number of shares of Quintiles common stock subject to each such option.
- [F2]Canceled for no consideration pursuant to the Merger Agreement.